Manufacturing, Aseptic Processing

Oct 12, 2017
By BioPharm International Editors
The company is investing EUR 170 million (US$201 million) to expand its vaccine manufacturing site in France for its newest influenza vaccine.
Oct 01, 2017
BioPharm International
This study outlines methods for an alternative protein-polishing process for challenging proteins.
Sep 27, 2017
By BioPharm International Editors
Fresenius Kabi broke ground on a previously announced $250 million expansion of its Melrose Park, IL, manufacturing facility.
Sep 01, 2017
BioPharm International
Protecting against microbiological contamination over the whole manufacturing process grows increasingly important.
Sep 01, 2017
BioPharm International
The control of biologics microbiological impurities, contaminants, and mimetics is evolving.
Sep 01, 2017
BioPharm International
Choosing a suitable material for fill/finish containers begins during the product development stage.
Aug 25, 2017
By BioPharm International Editors
Ajinomoto Althea’s Optima VFVM 7000 aseptic fill/finish line supports a range of drug substance APIs.
Jul 25, 2017
By BioPharm International Editors
FDA sent a warning letter to Sage Products, Inc. regarding CGMP failures involving test methods, sampling, and sterilization procedures.
Jun 26, 2017
By BioPharm International Editors
Fagron Sterile Services has voluntarily recalled three lots of Succinylcholine Chloride 20mg/mL 5mL syringe to the hospital/clinic level.
Jun 19, 2017
By BioPharm International Editors
The company has voluntarily recalled Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level because of a lack of sterility assurance.
native1_300x100
lorem ipsum